Anti-inflammatory therapy in the neonatal intensive care unit: present and future

Seminars in Fetal & Neonatal Medicine
Kristi Watterberg

Abstract

Inflammation has been linked to numerous adverse outcomes in newborns. This paper reviews several major sources of inflammation, methods to reduce exposure, current anti-inflammatory drug therapy and future research directions. The first major source of inflammation--chorioamnionitis--is often present long before delivery; postnatal interventions may not alter outcomes. Reducing the exposure of preterm infants to postnatal inflammatory stimuli such as mechanical ventilation and sepsis may be more effective than anti-inflammatory drug therapy in improving outcomes. If anti-inflammatory drug therapy is considered necessary, the only drug currently proven to decrease extubation failure and bronchopulmonary dsyplasia (BPD) is dexamethasone, which is associated with numerous side effects. Erythromycin treatment of Ureaplasma urealyticum has been ineffective in reducing BPD; are trials of azythromycin planned. Research may improve future outcomes by tailoring glucocorticoid dosage, duration and formulation in targeted populations and by developing agents to inhibit specific pro-inflammatory mechanisms.

References

Oct 1, 1991·The American Review of Respiratory Disease·S G Von EssenS I Rennard
Jan 1, 1996·European Journal of Clinical Pharmacology·R A LugoR E McClead
Nov 5, 1997·The New England Journal of Medicine·S W LambertsF H de Jong
May 18, 2000·The New England Journal of Medicine·R L GoldenbergW W Andrews
Oct 25, 2000·Pediatric Research·M W HuysmanP J Sauer
Mar 7, 2001·Pediatrics·B A BanksUNKNOWN North American Thyrotropin-Releasing Hormone Trial Collaborators
Feb 5, 2002·Pediatrics·UNKNOWN Committee on Fetus and Newborn
Feb 28, 2002·The Journal of Pediatrics·Linda J Van MarterUNKNOWN Developmental Epidemiology Network Investigators
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Feb 21, 2003·The New England Journal of Medicine·Mark S Cooper, Paul M Stewart
Apr 17, 2003·JAMA : the Journal of the American Medical Association·Dean FergussonStan Shapiro
Mar 27, 2004·The New England Journal of Medicine·Tsu F YehCheng H Tsai
May 7, 2004·Journal of Perinatology : Official Journal of the California Perinatal Association·Susan M Scott, Daniel F Cimino
Jun 24, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·O Flidel-RimonE S Shinwell
Jul 2, 2004·Journal of Paediatrics and Child Health·A Kent, J E Dahlstrom
Jan 11, 2005·The European Respiratory Journal·C Gras-Le GuenT Debillon
Feb 18, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Olaf DammannChristiane E L Dammann
Apr 19, 2005·Pediatrics·Marc-André DugasBruno Piedboeuf
Apr 30, 2005·Journal of Perinatology : Official Journal of the California Perinatal Association·Alan H Jobe
May 24, 2005·Journal of Perinatology : Official Journal of the California Perinatal Association·Robert LockePaul Fawcett

❮ Previous
Next ❯

Citations

Jan 28, 2009·Pediatrics·Juliette C MadanUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Apr 10, 2007·Seminars in Fetal & Neonatal Medicine·Adam J WolfbergPierre Gressens
Jan 13, 2018·Archives of Disease in Childhood. Fetal and Neonatal Edition·Olivier BaudUNKNOWN PREMILOC Trial group
Dec 8, 2017·Journal of Korean Medical Science·Se In SungWon Soon Park
Nov 5, 2011·Journal of Advanced Nursing·Katie GallagherDavina Porock
Jan 11, 2020·Acta Paediatrica·Nelly Padilla, Hugo Lagercrantz
Oct 17, 2019·Journal of Medical Ethics·Claudia BrickJulian Savulescu
Dec 29, 2016·Nursing Ethics·Janet Kelly, Emma Welch
Jun 12, 2014·Journal of Medical Ethics·Mirjam A de VosDick L Willems
Aug 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yu WangShijun J Zheng
Jun 2, 2009·Pediatrics·Anita Bhandari, Vineet Bhandari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.